Overview
- Offers a comprehensive overview of the current evidence on clinical trials in the field of ocular stem cell studies
- The first book to provide coverage on ocular stem cell studies around the world
- Covers active studies as well as completed, withdrawn, and terminated studies
Access this book
Tax calculation will be finalised at checkout
Other ways to access
About this book
This book is a compendium of the worldwide ocular stem cell studies registered with clinicaltrials.gov. The study title is provided, along with the country of origin and the clinical trial number in order to make it easier for the reader to locate the study and obtain further information. An analysis of the type of stem cell utilized and study support is also provided. The final section deals with issues encountered by the stem cell researchers.
Ocular Stem Cell Studies: A Comprehensive Overview of Global Clinical Trials is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers.
Similar content being viewed by others
Table of contents (9 chapters)
-
Front Matter
-
Back Matter
Authors and Affiliations
About the author
Jeffrey N. Weiss, M.D., is the former Chief of Retinal Surgery at the Joslin Diabetes Center in Boston, Faculty of Harvard Medical School, and Visiting Scientist at the Massachusetts Institute of Technology.
Dr. Weiss is the author of more than 100 publications, including 20 books, holds more than 20 U.S. and foreign patents and has been a Reviewer for multiple scholarly journals. He has served as a Visiting Professor, performed surgery, and lectured both nationally and internationally. Dr. Weiss is also the founder of two companies, Ocular Research Associates Inc., and Micron Ophthalmic, Inc., which have manufactured and sold Dr. Weiss’ inventions worldwide.
Dr. Weiss was the first to invent the equipment and develop the technique to safely perform retinal vessel cannulation. This surgery remains the only option for patients with severe stroke in the eye. He was also the first to report the use of hyperbaric oxygen treatment to successfully treat dry age-related macular degeneration and longer standing central retinal artery occlusions.
Dr. Weiss performed the first retinal stem cell surgery in 2010, and is the Principal Investigator of The Stem Cell Ophthalmology Treatment Studies I/II, the largest retinal and optic nerve stem cell studies in the world, and The Neurologic Stem Cell Treatment Study. The studies are Institutional Review Board (IRB) approved, registered with NIH, and listed on ClinicalTrials.gov.
Accessibility Information
PDF accessibility summary
This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com.
EPUB accessibility summary
This ebook is designed with accessibility in mind, aiming to meet the ePub Accessibility 1.0 AA and WCAG 2.0 Level AA standards. Its features include descriptions for images and other non-text content, as well as rich navigation that is compatible with screen readers. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com.
Bibliographic Information
Book Title: Ocular Stem Cell Studies
Book Subtitle: A Comprehensive Overview of Global Clinical Trials
Authors: Jeffrey N. Weiss
DOI: https://doi.org/10.1007/978-3-031-58557-9
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2024
Hardcover ISBN: 978-3-031-58556-2Published: 09 July 2024
Softcover ISBN: 978-3-031-58559-3Published: 10 July 2025
eBook ISBN: 978-3-031-58557-9Published: 08 July 2024
Edition Number: 1
Number of Pages: XIII, 359
Topics: Ophthalmology